Page last updated: 2024-08-25

rilmenidine and ALS - Amyotrophic Lateral Sclerosis

rilmenidine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cuic, B; Luikinga, SJ; Perera, ND; Rytova, V; Tomas, D; Turner, BJ; Wanniarachchillage, N1
Beart, PM; Horne, MK; Lau, CL; Perera, ND; Sheean, RK; Shin, YS; Turner, BJ1

Other Studies

2 other study(ies) available for rilmenidine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice.
    Neurobiology of disease, 2021, Volume: 154

    Topics: Amyotrophic Lateral Sclerosis; Animals; Antihypertensive Agents; Autophagy; DNA-Binding Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitophagy; Phenotype; Rilmenidine; TOR Serine-Threonine Kinases

2021
Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression.
    Autophagy, 2018, Volume: 14, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Animals; Autophagy; Disease Models, Animal; DNA-Binding Proteins; Humans; Mice, Transgenic; Motor Neurons; Rilmenidine; Superoxide Dismutase-1; TOR Serine-Threonine Kinases

2018
chemdatabank.com